» Articles » PMID: 7974720

The Distribution of HLA Antigens and Phenotypes Among Donors and Patients in the UNOS Registry

Overview
Journal Transplantation
Specialty General Surgery
Date 1994 Nov 27
PMID 7974720
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

We have analyzed HLA data from the UNOS registry on 20,230 patients on the renal waiting list in 1991 and 18,708 donors from 1988-1992. Significant differences were found in the distribution of HLA antigens for comparisons of the total donor pool and the various racial groups of patients as well as for inter- and intraracial comparisons of donors and patients. Within a racial group, the frequencies of blanks and of broad antigens were usually higher in patients while those of splits were usually higher in donors. Comparisons between the total donor pool and the various racial groups of patients showed that the likelihood of mismatch was greater for African-Americans and Hispanics than for Caucasians but that the chance of mismatch is high for all groups and the average number of antigens mismatched will not vary greatly among the different races. Heterogeneity, as measured by the percentage of the population with different phenotypes, was higher in African-Americans (97.2-99.7%) and Hispanics (97.7-99.4%) than in Caucasians (83.3-86.5%) because of multiple occurrences of a few phenotypes, most containing A1, B8 and DR3, in Caucasians. However, the most common phenotypes of Caucasian donors differed from those of Caucasian patients. All phenotypes were rare (0.007-0.61%) and, with the exception of a small group of Caucasian patients, the likelihood of achieving a good match is low, regardless of race. These data explain the observations that, with the exception of the phenotypically identical match, HLA matching does not influence organ distribution significantly.

Citing Articles

The Human Neonatal Skin Fibroblast, an Available Cell Source for Tissue Production and Transplantation, Exhibits Low Risk of Immunogenicity In Vitro.

Magne B, Ferland K, Savard E, Barbier M, Morissette A, Larouche D Int J Mol Sci. 2024; 25(13).

PMID: 39000078 PMC: 11241615. DOI: 10.3390/ijms25136965.


Immunologic Benefits of 0-antigen Mismatched Transplants: No Added Boost for Racial and Ethnic Minorities.

Caldwell J, Parvathinathan G, Stedman M, Ahearn P, Tan J, Cheng X Transplant Direct. 2024; 10(7):e1653.

PMID: 38881747 PMC: 11177818. DOI: 10.1097/TXD.0000000000001653.


Individual Lymphocyte Sensitivity to Steroids as a Reliable Biomarker for Clinical Outcome after Steroid Withdrawal in Japanese Renal Transplantation.

Okihara M, Takeuchi H, Kikuchi Y, Akashi I, Kihara Y, Konno O J Clin Med. 2021; 10(8).

PMID: 33924724 PMC: 8070672. DOI: 10.3390/jcm10081670.


The Importance of HLA Assessment in "Off-the-Shelf" Allogeneic Mesenchymal Stem Cells Based-Therapies.

Kot M, Baj-Krzyworzeka M, Szatanek R, Musial-Wysocka A, Suda-Szczurek M, Majka M Int J Mol Sci. 2019; 20(22).

PMID: 31766164 PMC: 6888380. DOI: 10.3390/ijms20225680.


Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.

Cole A, Johnson 2nd R, Egede L, Baliga P, Taber D Contemp Clin Trials Commun. 2018; 9:1-6.

PMID: 29532038 PMC: 5844505. DOI: 10.1016/j.conctc.2017.11.008.